This inventor holds 1 USPTO granted patent and 5 published patent applications and 2 EPO patents. Top assignee: Vanderbilt University. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Innovations in Diabetes Treatment by David Maggs
Introduction
David Maggs is an accomplished inventor based in Boston, MA. He has made significant contributions to the field of diabetes treatment through his innovative approaches. His work focuses on the co-administration of insulin and glucagon, which has the potential to improve the management of diabetes.
Latest Patents
David Maggs holds a patent for "Systems, compositions and methods for treating diabetes." This patent outlines methods for treatment that involve co-administering insulin and glucagon to a subject, as well as co-formulations that include both insulin and glucagon. This innovative approach aims to enhance the effectiveness of diabetes management.
Career Highlights
David Maggs is affiliated with Vanderbilt University, where he continues to advance research in diabetes treatment. His work is characterized by a commitment to improving patient outcomes through innovative solutions.
Collaborations
David has collaborated with notable colleagues, including Alan Cherrington and Soumitra S. Ghosh. These partnerships have contributed to the development of effective treatment methods and have fostered a collaborative research environment.
Conclusion
David Maggs is a pioneering inventor whose work in diabetes treatment exemplifies the impact of innovation in healthcare. His contributions are vital for advancing treatment options for individuals living with diabetes.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile